Currently out of the existing stock ratings of Michael Nedelcovych, 12 are a BUY (92.31%), 1 are a HOLD (7.69%).
Analyst Michael Nedelcovych, currently employed at TD COWEN, has had 68.06% of price targets met with an average potential upside of 14.58%, reached in 189 days on average.
Michael Nedelcovych has documented 26 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on JNJ, Johnson & Johnson at 13-Jul-2026.
Analyst best performing recommendations are on TAK (TAKEDA PHARMACEUTICAL CO LTD ADR).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) on 12/12/2022. The price target of $72.5 was fulfilled within 109 days with a profit of $13.75 (23.4%), with a performance score of 2.15.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 14-May-2025
$40
$-1.63 (-3.92%)
$47
1 months 5 days ago
(12-Oct-2026)
13/26 (50%)
$1.36 (3.52%)
29
Hold Since 11-Sep-2026
$40
$-1.63 (-3.92%)
$40
2 months 6 days ago
(11-Sep-2026)
4/4 (100%)
$-3.07 (-7.13%)
32
Buy Since 20-Nov-2025
$62
5 months ago
(17-Jun-2026)
1/2 (50%)
$15.28 (32.71%)
210
Hold Since 03-Jun-2026
$47
$5.37 (12.90%)
$41
5 months 14 days ago
(03-Jun-2026)
3/6 (50%)
$5.53 (13.33%)
41
Buy Since 07-Jun-2022
8 months 24 days ago
(24-Feb-2026)
10/10 (100%)
$32.06 (35.10%)
255
Which stock is Michael Nedelcovych most bullish on?
What Year was the first public recommendation made by Michael Nedelcovych?